ask="11.30"
ask_size="300"
average_daily_volume="251690"
bid="9.11"
bid_size="2200"
book_value="2.66"
change="-0.19"
change_from_200_day_moving_average="0.86"
change_from_50_day_moving_average="-0.35"
change_from_52_week_high="-1.38"
change_From_52_week_low="2.69"
change_in_percent="-1.92%"
close="9.69"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.30"
ebitda="-117.58M"
eps_estimate_current_year="-2.03"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-1.73"
ex_dividend_date="N/A"
float_shares="15511000"
high="9.81"
high_52_weeks="11.07"
last_trade_date="2/8/2017"
last_trade_price="9.69"
last_trade_size="5162"
last_trade_time="4:00pm"
low="9.60"
low_52_weeks="7.00"
market_capitalization="177.33M"
moving_average_200_day="8.83"
moving_average_50_day="10.04"
name="Akebia Therapeutics
Inc."
notes="N/A"
one_year_target_price="16.00"
open="9.81"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+9.73%"
percent_change_from_50_day_moving_average="-3.48%"
percent_change_from_52_week_high="-12.47%"
percent_change_from_52_week_low="+38.43%"
previous_close="9.88"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.72"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18300000"
short_ratio="3.69"
stock_exchange="NGM"
symbol="AKBA"
volume="120128"
weeks_range_52="7.00 - 11.07"
